Mounjaro and Gum Disease: What’s the Link? Written by Bolt Pharmacy Published on 17/4/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management. Whilst people with diabetes face increased risk of periodontal disease, there is no established direct link between Mounjaro and gum […]
Author Archives: premuimhash@gmail.com
Mounjaro After Gallbladder Removal: UK Safety Guide Written by Bolt Pharmacy Published on 5/5/2026 Mounjaro (tirzepatide) can generally be taken safely after gallbladder removal, with no absolute contraindication for post-cholecystectomy patients. This dual GLP-1 and GIP receptor agonist, licensed in the UK for type 2 diabetes management, requires careful consideration of your individual digestive function […]
Does Mounjaro Cause Numbness? UK Clinical Guidance Written by Bolt Pharmacy Published on 5/5/2026 Does Mounjaro cause numbness? This question concerns many patients prescribed tirzepatide for type 2 diabetes or weight management. Numbness and tingling (paraesthesia) are not listed as recognised adverse reactions in the UK Summary of Product Characteristics for Mounjaro. However, patients may […]
Mounjaro Injection and Alcohol: UK Safety Guidelines Written by Bolt Pharmacy Published on 17/4/2026 Mounjaro (tirzepatide) is a once-weekly injectable medication licensed in the UK for type 2 diabetes mellitus, and as Zepbound for weight management in adults with obesity. Many patients wonder whether it is safe to drink alcohol whilst taking Mounjaro injection and […]
Digestive Enzymes and Mounjaro: Safety and Management Guide Written by Bolt Pharmacy Published on 14/5/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management. As with many GLP-1-based therapies, gastrointestinal side effects such as nausea, bloating, and altered digestion are common, leading some […]
Will Mounjaro Get Rid of Belly Fat? UK Clinical Evidence Written by Bolt Pharmacy Published on 17/4/2026 Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for type 2 diabetes and weight management in adults with obesity or overweight with weight-related conditions. As a dual GIP/GLP-1 receptor agonist, it reduces appetite and supports substantial […]
When to Resume Mounjaro After Surgery: UK Guidance Written by Bolt Pharmacy Published on 22/7/2026 Mounjaro (tirzepatide) is a GLP-1 and GIP receptor agonist used for type 2 diabetes and weight management in the UK. When to resume Mounjaro after surgery depends on the procedure type, recovery progress, and gastrointestinal function. Surgical teams typically advise […]
Green Poop: Causes, When to Worry & What It Means Written by Bolt Pharmacy Published on 5/5/2026 Green stools whilst taking Mounjaro (tirzepatide) can understandably cause concern, but this colour change is typically benign and temporary. Mounjaro, a dual GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes mellitus, commonly affects […]
What Colour Is Mounjaro? UK Pen Identification Guide Written by Bolt Pharmacy Published on 17/4/2026 Mounjaro (tirzepatide) is a once-weekly injectable medication licensed in the UK for type 2 diabetes and weight management. The pre-filled pens use a colour-coded system to help identify different dosage strengths—2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, […]
Mounjaro and Skin Tags: Effects, Management and Advice Written by Bolt Pharmacy Published on 10/6/2026 Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management in adults with obesity or overweight with comorbidities. As patients experience substantial weight reduction, many notice various skin changes, including concerns […]